With the availability of potent lifesaving and less-toxic antiretroviral (ARV) agents, HIV-1 is now managed as a chronic disease.
At the completion of this activity, the pharmacist will be able to:
- Discuss effective pharmacological strategies for HIV-1 prophylaxis.
- List three antiretroviral regimens, including dosing, adverse reactions, and drug interactions recommended by current antiretroviral guidelines in individuals with HIV-1 infection
. Describe drug interaction differences between cobicistat and ritonavir when used as pharmacokinetic boosters . Discuss newer treatment strategies for managementof HIV-1 infection.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-261-H02-P.
To obtain credit for HIV-1 Update 2018 complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: October 1, 2018
Expiration date: October 1, 2021 - NO CREDIT GRANTED AFTER THIS DATE
HIV-1 Update 2018 is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.
Betty J. Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP
Professor of Clinical Pharmacy and Family and Community Medicine
University of California Schools of Pharmacy and Medicine, San Francisco
Kristina Brooks, PharmD
Postdoctoral Fellow, Department of
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
Betty J. Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP, declares that she has received honoraria as a speaker or consultant for the American College of Clinical Pharmacy, Pharmacy Times, and Healthline.com.
Kristina Brooks, PharmD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. Please visit our website and view the Technology System Requirements to have a positive learning experience.